Home › Aplastic Anemia › Maryland
Aplastic Anemia clinical trials in Maryland
10 studies for Aplastic Anemia are looking for participants at sites in Maryland.
Cities in Maryland
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 12 to 120 · All sexes · Updated Oct 2, 2026 · NCT06303193Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 4 to 75 · All sexes · Updated Oct 1, 2026 · NCT03173937Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 2 to 99 · All sexes · Updated Sep 30, 2026 · NCT05012111Cancer in Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
- National Cancer Institute - Shady Grove, Rockville
RecruitingObservational studyHealthy volunteers welcome
1 Day – 100 Years · All sexes · Updated Sep 30, 2026 · NCT00027274Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06398457Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 4 to 80 · All sexes · Updated Sep 22, 2026 · NCT01174108Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 4 to 75 · All sexes · Updated Sep 8, 2026 · NCT03520647A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 3 to 99 · All sexes · Updated Mar 9, 2026 · NCT04304820Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
- Johns Hopkins University, Baltimore
RecruitingPhase 2
Ages 3 to 75 · All sexes · Updated Feb 17, 2026 · NCT06517641From ClinicalTrials.gov, data retrieved Oct 4, 2026. Each study sets its own eligibility; the study team decides who can join.